LUCIAN V. DEL PRIORE, M.D., Ph.D. Robert L. Burch III Scholar ...

Del Priore: curriculum vitae Page 11
Purpose: To compare the visual acuity outcome among three groups of participants: those
who are randomly assigned to receive standard care and those randomly assigned to receive
one of two doses of intravitreal injection(s) of triamcinolone acetonide for treatment of
macular edema associated with central retinal vein occlusion (CRVO) and branch retinal vein
occlusion (BRVO).
3. “A Six-Month, Phase 3, Multicenter, Masked, Randomized, Sham- Controlled Trial (with
Six-Month Open-Label Extension) to Assess the Safety and Efficacy of 700 mcg and 350
mcg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator
System in the Treatment of Patients with Macular Edema Following Central Retinal Vein
Occlusion or Branch Retinal Vein Occlusion” (POSURDEX for B/CRVO)
Primary Investigator: William Schiff, M.D.
Co-investigators: Gaetano Barile, M.D.; Stanley Chang, M.D.; Lucian V. Del Priore, M.D.,
Ph.D.
Sponsor: Allergan, Inc.
Status: CUMC IRB approval obtained.
Purpose: To investigate the safety and effectiveness of Dexamethasone Posterior Drug
Delivery System (DEX PS DDS) in the treatment of macular edema due to central or branch
retinal vein occlusion.
4. “A 3-Year, Phase 3, Multicenter, Masked, Randomized, Sham-controlled Trial to Assess
the Safety and Efficacy of 700 mcg and 350 mcg Dexamethasone Posterior Segment Drug
Delivery System (DEX PS DDS) Applicator System in the Treatment of Patients with
Diabetic Macular Edema” (POSURDEX in Diabetic Macular Edema)
Primary Investigator: William Schiff, M.D.
Co-investigators: Gaetano Barile, M.D.; Stanley Chang, M.D.; Lucian V. Del Priore, M.D.,
Ph.D.
Sponsor: Allergan, Inc.
Status: Pending CUMC IRB approval.
Purpose: To investigate the safety and effectiveness of Dexamethasone Posterior Drug
Delivery System (DEX PS DDS) in the treatment of patients with diabetic macular edema.
5. “Diabetic Retinopathy Clinical Research Network (DRCRNet) Protocol #3: Temporal
Variation in Optical Coherence Tomography Measurements of Retinal Thickening in
Diabetic Macular Edema” (OCT in DME)
Primary Investigator: Gaetano Barile, M.D.
Co-investigators: Stanley Chang, M.D.; Lucian V. Del Priore, M.D., Ph.D.; William Schiff,
M.D.
Sponsor: NIH/NEI
Status: CUMC IRB approval obtained.
Purpose: The study is designed to find out if the amount of macular swelling due to Diabetic
Macular Edema, changes over the course of the day as per OCT measurements. Secondly, it
aims to find out more information on the accuracy of the OCT test.
6. “DRCRNet Protocol #2: A Randomized Clinical Trial Comparing Intravitreal
Triamcinolone Acetonide and Laser Photocoagulation for Diabetic Macular Edema” (IVTA